| Controlling chitosan-based encapsulation for protein and vaccine delivery B prasanth Koppolu, SG Smith, S Ravindranathan, S Jayanthi, ... Biomaterials 35 (14), 4382-4389, 2014 | 156 | 2014 |
| Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy S Iyer, S Zhang, S Yucel, H Horn, SG Smith, F Reinhardt, E Hoefsmit, ... Cancer Discovery 11 (2), 384-407, 2021 | 103 | 2021 |
| Tuning nanoparticle interactions with ovarian cancer through layer-by-layer modification of surface chemistry S Correa, N Boehnke, AE Barberio, E Deiss-Yehiely, A Shi, B Oberlton, ... Acs Nano 14 (2), 2224-2237, 2020 | 97 | 2020 |
| Effect of chitosan properties on immunoreactivity S Ravindranathan, BP Koppolu, SG Smith, DA Zaharoff Marine drugs 14 (5), 91, 2016 | 72 | 2016 |
| Cancer cell coating nanoparticles for optimal tumor-specific cytokine delivery AE Barberio, SG Smith, S Correa, C Nguyen, B Nhan, M Melo, T Tokatlian, ... ACS nano 14 (9), 11238-11253, 2020 | 66 | 2020 |
| Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer SG Smith, BP Koppolu, S Ravindranathan, SL Kurtz, L Yang, MD Katz, ... Cancer immunology, immunotherapy 64, 689-696, 2015 | 63 | 2015 |
| Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis JLN Vo, L Yang, SL Kurtz, SG Smith, BP Koppolu, S Ravindranathan, ... Oncoimmunology 3 (12), e968001, 2014 | 56 | 2014 |
| Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccines S Ravindranathan, KG Nguyen, SL Kurtz, HN Frazier, SG Smith, ... Breast Cancer Research 20, 1-17, 2018 | 47 | 2018 |
| Acetazolamide mitigates astrocyte cellular edema following mild traumatic brain injury NM Sturdivant, SG Smith, SF Ali, JC Wolchok, K Balachandran Scientific reports 6 (1), 33330, 2016 | 47 | 2016 |
| Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer SG Smith, JL Baltz, BP Koppolu, S Ravindranathan, K Nguyen, ... Oncoimmunology 6 (1), e1259050, 2017 | 46 | 2017 |
| Future directions in bladder cancer immunotherapy: towards adaptive immunity SG Smith, DA Zaharoff Immunotherapy 8 (3), 351-365, 2016 | 40 | 2016 |
| Modulation of Interleukin-12 activity in the presence of heparin S Jayanthi, BP Koppolu, KG Nguyen, SG Smith, BK Felber, TKS Kumar, ... Scientific reports 7 (1), 5360, 2017 | 34 | 2017 |
| Efficient production and purification of recombinant human interleukin-12 (IL-12) overexpressed in mammalian cells without affinity tag S Jayanthi, B prasanth Koppolu, SG Smith, R Jalah, J Bear, M Rosati, ... Protein expression and purification 102, 76-84, 2014 | 25 | 2014 |
| Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors AE Barberio, SG Smith, IS Pires, S Iyer, F Reinhardt, MB Melo, H Suh, ... Bioengineering & Translational Medicine 8 (2), e10453, 2023 | 21 | 2023 |
| Analyzing the effects of instillation volume on intravesical delivery using biphasic solute transport in a deformable geometry SG Smith, BE Griffith, DA Zaharoff Mathematical Medicine and Biology: a Journal of the IMA 36 (2), 139-156, 2019 | 7 | 2019 |
| Cytokine-chitosan bioconjugates and methods of using the same DA Zaharoff, SK Thallapuranam, B prasanth Koppolu, S Jayanthi, ... US Patent App. 15/315,097, 2017 | 1 | 2017 |
| Layer-by-layer nanoparticles for the non-toxic delivery of interleukin-12 to orthotopic ovarian cancer S Smith, A Barberio, D Irvine, S Correa, C Nguyen, M Melo, T Tokatlian, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | | 2019 |
